TOP 50 Companies Worldwide Ranking Company Industry Revenue FY Capitalization Employees Listing Headquarters CEO 1 Exxon Mobil Corporation Oil and gas $482.295 December 31‚ 2012 $408.78 76‚9 NYSE: XOM United States Irving‚ Texas Rex W. Tillerson 2 Royal Dutch Shell Oil and gas $481.7 December 31‚ 2012 $236.34 90 LSE: RDSA Netherlands The Hague; United Kingdom London Peter Voser 3 Walmart Retail $469.162 January 31‚ 2013 $208.36 2‚200‚000 NYSE: WMT United
Premium 1986 1966 1970
Sector briefing Pharmaceutical Opportunities in Bangladesh. WHY BANGLADESH? Pharmaceutical is one of the highest priority sectors in Bangladesh. With an annual twodigit growth rate the Bangladesh pharmaceutical industry is now heading towards self – sufficiency in meeting local demand. With over US$250 million investments in the pharmaceutical industry of Bangladesh the sector has emerged as the country’s most developed hi-tech one that contributes significantly to the national economy
Premium Pharmacology International trade Pharmaceutical industry
Objective of the report: The Bangladesh paradox has been one of surprising economic resilience in the face of natural disasters‚ poor governance and political volatility. However‚ a key challenge is whether Bangladesh can move away from an economy that is an impressive underdog‚ to one that can truly join the ranks of the fastest growing economies in the region. Bangladesh has three key attractions for global investors and multinationals: a large base of low-cost labour‚ a large domestic
Premium Investment
Bangladesh Pharmaceutical Industry By Sarker Imran‚ RRU‚ BC‚ Canada | | There are several sectors on which Bangladesh can be proud of and undoubtedly the pharmaceutical sector is one of these sectors‚ rather it is the sector‚ which is the second-largest contributor to the government exchequer. There are about 231 companies in this sector and the approximate total market size is about Taka 76‚500 million per year of which about 97% of the total requirement of medicines is created by the
Premium World Trade Organization International trade General Agreement on Tariffs and Trade
(Online) www.iiste.org Financial Analysis of Selected Pharmaceutical Companies in Bangladesh Md. Tofael Hossain Majumder (Corresponding Author) Lecturer‚ Department of Accounting and Information Systems Comilla University‚ Comilla‚ Bangladesh. Phone: +8801816436176‚ Email: tofael_cou@yahoo.com Mohammed Mizanur Rahman Lecturer‚ School of Business and Economics Atish Dipankar University of Science and Technology‚ Dhaka‚ Bangladesh. Phone: +8801814319485‚ Email: mizancu@yahoo.com Abstract
Premium Financial ratios Financial ratio Generally Accepted Accounting Principles
1) PHARMACEUTICAL INDUSTRY ANALYSIS 1.1 Industry Background: The total industry can broadly be classified into two categories. Theses are a) Patent Medicines b) Generic Medicines Patent medicines are the products that are invented by the company‚ who have their own research team working on their own laboratories. These products are patented for many years to enjoy the monopoly market. After years of business the formulation is sold in the market so that others can go into mass production
Premium Pharmaceutical industry Pharmacology Patent
a lot of discussion about pharmaceutical companies‚ intellectual property‚ and the global AIDS epidemic. Do pharmaceutical companies have a responsibility to distribute drugs for free or low cost in developing countries? Why is intellectual property such a big deal? What impact would South Africa’s decision to levy duties on drugs in the country have on the international distribution of drugs? Was the change that provided patent protection for pharmaceutical companies an appropriate change or
Premium Generic drug Developing country Developed country
Questions for Review 1. Pharmaceutical companies do have a responsibility to distribute drugs for a low cost in developing and poorer countries. Africa’s GDP‚ and per capita income is very low so they cannot afford to buy top quality medicines. One main argument for this approach is the AIDS epidemic in Africa. A main argument against this is that the treatment for AIDS is very expensive to provide to a whole country for free. 2. The principal arguments of pharmaceutical companies that oppose making
Premium HIV World Trade Organization Pharmacology
business of Pharmaceutical companies:- Pharmaceutical companies are not especially big in terms of revenues‚ but they are very profitable. For instance‚ in 2001‚ Pfizer was ranked 127th in the world on total revenue (US$32·2 billion) but 7th in terms of profit.29 The pharmaceutical industry is the most profitable business sector‚ with an average 16·2% profit‚ ahead of financial companies (11·6%) and beverages (10%).30 However‚ net income growth has declined‚ and growth in the value of drug
Premium Pharmacology Profit Income
of Pharmaceutical Company in Bangladesh Faruk Hossan Md Ahsan Habib Supervisor: José Ferraz Nunes Examiner: Bengt Kjellén Master‟s thesis in international Business 15 ECTS Department of Economic and Informatics University West Spring term 2010 0 ABSTRACT The thesis applies performance evaluation of pharmaceutical company in Bangladesh. It means evaluate how well the company performs. The main aim is achieved through ratio analysis of two pharmaceutical (Beximco and Square pharmaceutical) companies
Premium Financial ratios Generally Accepted Accounting Principles Balance sheet